Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted January 16, 2018
Marketers of CellAssure and Cognify Settle FTC Charges of Deceptive Cancer Claims
On January 11, 2018, the FTC announced that CellMark Biopharma, LLC and its CEO, Derek E. Vest have agreed to settle charges that it made false claims about its products, CellAssure and Cognify, which were marketed as treatments for the effects of cancer and chemotherapy such as weight loss, malnutrition, and cognitive dysfunction.